Insider Transactions in Q4 2021 at Arvinas, Inc. (ARVN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-53.13%
|
$1,600,000
$80.65 P/Share
|
|
Dec 30
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.11%
|
$720,000
$36.98 P/Share
|
|
Dec 17
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-8.66%
|
$1,050,000
$70.0 P/Share
|
|
Dec 17
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.97%
|
$240,000
$16.0 P/Share
|
|
Dec 16
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
85,705
-17.28%
|
$5,913,645
$69.32 P/Share
|
|
Dec 15
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
113,536
-10.71%
|
$7,493,376
$66.57 P/Share
|
|
Dec 14
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
156,464
-10.28%
|
$10,170,160
$65.2 P/Share
|
|
Nov 15
2021
|
Ian Taylor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.27%
|
$1,680,000
$84.05 P/Share
|
|
Nov 15
2021
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.58%
|
$340,000
$17.68 P/Share
|
|
Nov 15
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
21,284
-1.9%
|
$1,787,856
$84.49 P/Share
|
|
Nov 12
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
39,869
-2.25%
|
$3,348,996
$84.76 P/Share
|
|
Nov 11
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
59,799
-3.08%
|
$5,142,714
$86.67 P/Share
|
|
Nov 10
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
13,358
-0.4%
|
$1,175,504
$88.23 P/Share
|
|
Nov 09
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
33,008
-1.56%
|
$3,003,728
$91.97 P/Share
|
|
Nov 08
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
81,054
-2.64%
|
$7,538,022
$93.66 P/Share
|
|
Nov 05
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
33,094
-0.82%
|
$3,011,554
$91.97 P/Share
|
|
Nov 05
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Direct |
24,923
-58.27%
|
$2,243,070
$90.88 P/Share
|
|
Nov 05
2021
|
Liam Ratcliffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,423
+32.85%
|
$497,421
$27.82 P/Share
|
|
Nov 01
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-1.55%
|
$3,480,000
$87.99 P/Share
|
|
Nov 01
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+4.38%
|
$640,000
$16.0 P/Share
|